Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
D’Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean‐Yves, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna M., Piperno‐Neumann, Sophie, Martin‐Broto, Javier, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Chevreau, Christine, Sherriff, Jenny, Estival, Anna, Litière, Saskia, Sents, Ward, Ray‐Coquard, Isabelle, Tolomeo, Francesco, Le Cesne, Axel, Rutkowski, Piotr, Stacchiotti, Silvia, Kasper, Bernd, Gelderblom, Hans, Gronchi, Alessandro
Published in Cancer (01.06.2020)
Published in Cancer (01.06.2020)
Get full text
Journal Article
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials
Mir, Olivier, Touati, Nathan, Lia, Michela, Litière, Saskia, Le Cesne, Axel, Sleijfer, Stefan, Blay, Jean-Yves, Leahy, Michael, Young, Robin, Mathijssen, Ron H J, Van Erp, Nielka P, Gelderblom, Hans, Van der Graaf, Winette T, Gronchi, Alessandro
Published in Clinical cancer research (01.03.2019)
Published in Clinical cancer research (01.03.2019)
Get full text
Journal Article
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial
Italiano, Antoine, Touati, Nathan, Litière, Saskia, Collin, Françoise, Pourquier, Philippe, Gronchi, Alessandro
Published in Cancer medicine (Malden, MA) (01.05.2018)
Published in Cancer medicine (Malden, MA) (01.05.2018)
Get full text
Journal Article
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
Wildiers, Hans, Tryfonidis, Konstantinos, Dal Lago, Lissandra, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Altintas, Sevilay, Touati, Nathan, Cardoso, Fatima, Brain, Etienne
Published in The lancet oncology (01.03.2018)
Published in The lancet oncology (01.03.2018)
Get full text
Journal Article
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
Pasquali, Sandro, Pizzamiglio, Sara, Touati, Nathan, Litiere, Saskia, Marreaud, Sandrine, Kasper, Bernd, Gelderblom, Hans, Stacchiotti, Silvia, Judson, Ian, Dei Tos, Angelo P., Verderio, Paolo, Casali, Paolo G., Woll, Penella J., Gronchi, Alessandro
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study
Gillon, Pauline, Touati, Nathan, Breton-Callu, Christel, Slaets, Leen, Cameron, David, Bonnefoi, Hervé
Published in European journal of cancer (1990) (01.07.2017)
Published in European journal of cancer (1990) (01.07.2017)
Get full text
Journal Article
LBP-028 Effect of elafibranor on pruritus in primary biliary cholangitis: symptom severity and quality of life measurements from the phase III ELATIVE® trial
Kremer, Andreas E., Kowdley, Kris V., Levy, Cynthia, J. Mayo, Marlyn, Schattenberg, Jörn M., Antunes, Nuno, Böing, Elaine, Tonev, Dimitar, Touati, Nathan, Jones, David
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
Bowlus, Christopher L., Kowdley, Kris V., Levy, Cynthia, Akarca, Ulus, Álvares-da-Silva, Mario, Andreone, Pietro, Arrese, Marco, Corpechot, Christophe, Francque, Sven, Heneghan, Michael, Invernizzi, Pietro, Jones, David, Kruger, Frederik, Lawitz, Eric, Mayo, Marlyn J., Shiffman, Mitchell, Swain, Mark G., Valera, Jose Miguel, Blasco, Victor Vargas, Vierling, John M., Villamil, Alejandra, Dietrich, Julie, Shu, Jianfen, Antunes, Nuno, Sleiman, Marwan, Touati, Nathan, Schattenberg, Jorn M.
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials
Vos, Melissa, Sleijfer, Stefan, Litière, Saskia, Touati, Nathan, Duffaud, Florence, van der Graaf, Winette T., Gelderblom, Hans
Published in Acta oncologica (03.06.2019)
Published in Acta oncologica (03.06.2019)
Get full text
Journal Article
Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931
Pasquali, Sandro, Pizzamiglio, Sara, Touati, Nathan, Litiere, Saskia, Marreaud, Sandrine, Kasper, Bernd, Gelderblom, Hans, Stacchiotti, Silvia, Verderio, Paolo, Casali, Paolo Giovanni, Woll, Penella, Gronchi, Alessandro
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer
Touati, Nathan, Tryfonidis, Konstantinos, Caramia, Franco, Bonnefoi, Hervé, Cameron, David, Slaets, Leen, Parker, Belinda S, Loi, Sherene
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Doxorubicin plus dacarbazine (DoDa), doxorubicin plus ifosfamide (DI) or doxorubicin alone (Do) as first line treatment for advanced leiomyosarcoma (LMS): A retrospective study from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG)
D'Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean-Yves, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna Malgorzata, Piperno-Neumann, Sophie, Martin Broto, Javier, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Kasper, Bernd, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Litiere, Saskia, Sents, Ward, Gelderblom, Hans, Gronchi, Alessandro
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial
Aalders, Kim C., Touati, Nathan, Tryfonidis, Konstantinos, Annonay, Mylène, Litiere, Saskia, Bergh, Jonas, Bodmer, Alexandre, Cameron, David A., Bonnefoi, Hervé R.
Published in Breast cancer research and treatment (01.06.2018)
Published in Breast cancer research and treatment (01.06.2018)
Get full text
Journal Article